In the case of intestinal barrier disruption caused by enteric pathogen (C. rodentium) infection, genetic ablation of CRAMP further promotes the gut barrier disruption, intestinal IFN-γ+ T cell recruitment and their migration to the pancreas, ultimately exacerbating diabetes. Here, IFNG is linked to diabetes mellitus.